Deferred Tax Assets, Valuation Allowance of Tempest Therapeutics, Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Tempest Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • Tempest Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $176,799,000, a 7.4% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Tempest Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $176,799,000 +$12,156,000 +7.4% 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q4 2023 $164,643,000 +$9,129,000 +5.9% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q4 2022 $155,514,000 +$8,581,000 +5.8% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q4 2021 $146,933,000 +$117,860,000 +405% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q4 2020 $29,073,000 -$86,287,000 -75% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q4 2019 $115,360,000 +$7,309,000 +6.8% 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q4 2018 $108,051,000 +$78,946,000 +271% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q4 2017 $29,105,000 -$41,617,000 -59% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q4 2016 $70,722,000 +$21,511,000 +44% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 $49,211,000 +$12,302,000 +33% 31 Dec 2015 10-K 02 Mar 2017 2016 FY
Q4 2014 $36,909,000 +$19,241,000 +109% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q4 2013 $17,668,000 +$11,740,000 +198% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q4 2012 $5,928,000 +$4,951,000 +507% 31 Dec 2012 10-K 27 Feb 2014 2013 FY
Q4 2011 $977,000 31 Dec 2011 10-K 25 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.